Injectable Nordictropin 120iu HGH

Dosage & Administration:

Administer by subcutaneous injection to the back of upper arm, abdomen, buttock, or thigh with regular rotation of injection sites

Pediatric Dosage - divide the calculated weekly dosage into equal doses given either 6, or 7 days per week

GHD: 0.17 mg/kg/week to 0.24 mg/kg/week

Noonan Syndrome: Up to 0.46 mg/kg/week

Turner Syndrome: Up to 0.47 mg/kg/week

SGA: Up to 0.47 mg/kg/week

ISS: Up to 0.47 mg/kg/week

Prader-Willi Syndrome: 0.24 mg/kg/week

Adult Dosage: Either of the following two dosing regimens may be used:

Non-weight based dosing: Initiate with a dose of approximately 0.2 mg/day (range, 0.15 mg/day-0.3 mg/day) and increase the dose every 1-2 months by increments of approximately 0.1 mg/day-0.2 mg/day, according to individual patient requirements

Weight-based dosing (Not recommended for obese patients): Initiate at 0.004 mg/kg daily and increase the dose according to individual patient requirements to a maximum of 0.016 mg/kg daily

How to Stock the Norditcropin:

Nordictropin products must be refrigerated (36°F to 46°F) prior to first use.

Do not freeze and avoid direct light. After first injection, Norditropin pens can either be stored outside of the refrigerator (up to 77°F) for use within 3 weeks, or in the refrigerator (between 36°F and 46°F) for use within 4 weeks.

What is growth hormone?

A role of growth hormone is to tell organs, tissues, and other parts of the body to grow. Knowing exactly how it functions in the body will help you understand the mechanics of treatment with Norditropin.

Description :

NORDITROPIN is a prescription medicine that contains human growth hormone, the same growth hormone made by the human body.

NORDITROPIN is given by injection under the skin (subcutaneous) and is used to treat:

children who are not growing because of low or no growth hormone.

children who are short (in stature) and who have Noonan syndrome, Turner syndrome, or were born small (small for gestational age-SGA) and have not caught-up in growth by age 2 to 4 years.

children who have Idiopathic Short Stature (ISS).

children who are not growing who have Prader-Willi syndrome (PWS).

adults who do not make enough growth hormone.